Both an innovator and a biosimilar player – an innovator perspective on developing a global biosimilar strategy
Download this presentation now to find out about the biosimilar market from a true innovator. This is the presentation you need to learn more about:
- The EU biosimilars landscape is growing fast
- Amgen is leveraging its leading biotech expertise to introduce High quality Biosimilars-mAbs
- Manufacturing processes of biologics are distinct and unique to each manufacturer
- Reverse-engineering is required and can pose challenges to biosimilar design
- The challenge with biologics is knowing which differences matter clinically
Thank you for your interest. To receive your copy of the PDF, please fill in the form to your right.
Thanks,
World Biosimilar Congress Team